Athersys to cut up to 70% of its workers in effort to survive
June 02, 2022 at 18:35 PM EDT
Athersys has been developing its MultiStem adult stem cell therapy since 1994 but has a hard time commercializing it.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
